Demirok Aysenur, Nagelkerke Sjoerd C J, Veldt Malou, Gorter Ramon, de Jong Justin R, Damen Gerard M, de Koning Barbara A E, Meijer Caroline, van Rheenen Patrick F, Wolters Victorien M, Benninga Marc A, Tabbers Merit M
Department of Pediatric Gastroenterology, Hepatology and Nutrition, Emma Children's Hospital, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Department of Pediatric Surgery, Emma Children's Hospital, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
J Pediatr Gastroenterol Nutr. 2025 Jan;80(1):34-45. doi: 10.1002/jpn3.12400. Epub 2024 Nov 1.
To describe incidence, clinical course, diagnostic and therapeutic management and long-term follow-up of paediatric intestinal pseudo-obstruction (PIPO) in the Netherlands between 2000 and 2020.
Multicenter, national, retrospective, observational study including patients aged <18 years diagnosed with PIPO and treated between 2000 and 2020 in Dutch academic medical centres. Outcomes included demographics, incidence, symptoms, diagnostic- and treatment methods used during follow-up, number of hospital admissions and mortality.
Between 2000 and 2020, 43 children (median age 120 months, range 13-301, 54% female) were diagnosed with PIPO in the Netherlands. Mean incidence was 0.008/100,000/years (range 0/100 000-0.029/100 000). Twenty-six patients developed PIPO in the neonatal period. Initial symptoms were vomiting (n = 21/35, 60%) and abdominal distension (n = 14/35, 40%). Diagnostic strategies included imaging, manometry, histopathology, metabolic- and genetic screening, endoscopy and exploratory surgery. Treatment was divided in nutritional support, pharmacotherapy, colonic irrigation and surgical interventions, of which nutrition and surgery were the cornerstones for care. During the observed study period, the median number of hospital admissions was 22.5 (range 1-176) with a median of 157.5 days (range 3-840) during 20-year follow-up. Two patients (6%) died: one from sepsis and one due to a severe underlying neurological disease. Heterogeneity in diagnostic- en treatment methods existed between patients.
PIPO is a rare, long-lasting complex disease requiring a high number of diagnostic and therapeutic interventions and hospital admissions. However, mortality rate is relatively low. Based on our results, we recommend centralization and standardization of care for this complex rare disease.
描述2000年至2020年间荷兰儿童肠道假性梗阻(PIPO)的发病率、临床病程、诊断和治疗管理以及长期随访情况。
多中心、全国性、回顾性观察研究,纳入2000年至2020年间在荷兰学术医疗中心诊断为PIPO并接受治疗的18岁以下患者。结局指标包括人口统计学特征、发病率、症状、随访期间使用的诊断和治疗方法、住院次数和死亡率。
2000年至2020年间,荷兰有43名儿童(中位年龄120个月,范围13 - 301个月,54%为女性)被诊断为PIPO。平均发病率为0.008/10万/年(范围0/10万 - 0.029/10万)。26例患者在新生儿期发生PIPO。初始症状为呕吐(n = 21/35,60%)和腹胀(n = 14/35,40%)。诊断策略包括影像学检查、测压、组织病理学检查、代谢和基因筛查、内镜检查及探查性手术。治疗分为营养支持、药物治疗、结肠灌洗和手术干预,其中营养和手术是治疗的基石。在观察研究期间,中位住院次数为22.5次(范围1 - 176次),20年随访期间中位住院天数为157.5天(范围3 - 840天)。2例患者(6%)死亡:1例死于败血症,1例死于严重的潜在神经疾病。患者之间在诊断和治疗方法上存在异质性。
PIPO是一种罕见的、病程持久的复杂疾病,需要大量的诊断和治疗干预以及住院治疗。然而,死亡率相对较低。基于我们的研究结果,我们建议对这种复杂的罕见疾病进行集中化和标准化治疗。